Alterity Therapeutics News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 1 01:16

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 24 01:18

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 10 01:19

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 30 20:05

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 18:22

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 18:18

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 18 01:01

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 15 20:03

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 12 20:02

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 26 20:04

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 16 00:59

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 4 21:05

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 4 21:05

Alterity Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 1 00:59

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 24 01:15

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 24 01:15

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 24 01:15

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 23 01:07

Alterity Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 20 21:03

Alterity Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 16 06:34